Currently, Larry Mattheakis is Chief Scientific Officer & Executive VP at Annexon, Inc.

In the past he was Senior Scientist at Cytokinetics, Inc., Associate Director at Exelixis, Inc., SVP-Discovery Biology & Translational Research at Protagonist Therapeutics, Inc. and Assistant Director at Affymax Research Institute.

Larry Mattheakis received a graduate degree and a doctorate from the University of Wisconsin and an undergraduate degree from the University of California.